TLPH Rasio cepet Talphera, Inc.

The confirmed price history on the separate_ratio_quick chart is fixed at 4.14. Talphera, Inc. (TLPH) generates revenue by supplying advanced analgesic delivery systems to hospitals, where payment is guaranteed by insurance structures. Sales stability and high margins are supported by an extensive network of specialized temperature-controlled warehouses. Current cash flow is driven by sales of approved sublingual products, while reorganization costs have already been priced in by the market.

This indicator measures a company's ability to immediately settle short-term debts using its most liquid assets, completely excluding hard-to-sell inventories from the calculation. For Talphera, Inc. (TLPH), which has pivoted its profile toward the development of emergency medications, changes in the acid-test ratio demonstrate financial stability during the commercialization of new solutions, defining the business's margin of safety excluding warehouse stocks.